Laurent Castera

Professor of Hepatology, University of Paris-VII and Visiting Professor of Medicine, UCL
When
28th-29th Apr 2021
Registration from 8am
Where
Virtual
Exploring factors for advances in treatment – such as:
Latest Clinical Trial Data Session
This session will compose of an overview of what was learned from phase 2/3 trials in 2019 followed by a series of flash presentations where clinical trial data sets will be presented.
Clinical Development & Trial Design Optimization
Panel Discussion
Roundtable Discussions
Director International Clinical Development NASH, Allergan
Executive Vice President, Non Clinical Development, Co-Founder, Poxel, France
Professor, Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, USA
President and Chief Executive Officer, Galectin Therapeutics Inc. USA
Vice President, Clinical Development – Liver Disease, Allergan
Associate Professor in clinical nutrition, Head of Clinical Research Unit, Uppsala University, Sweden
Senior Clinical Lecturer in Endocrinology, Department of Metabolism, Digestion and Reproduction, Imperial College, UK
Consultant Hepatologist, Queen Alexandra Hospital, UK
Principal Technical Adviser, NICE Scientific Advice
CEO Liver Consulting ; Former Head of Liver Disease Development, Takeda
Chief Medical officer, SomaLogic
Research Director of Cardiometabolic Risk Unit, Institute of Clinical Physiology, CNR, Pisa Italy & Professor of Medicine, UT Health Science Center San Antonio, TX, USA
Chief Medical Officer, Danish Medicines Agency, Consultant Gastroenterologist, Odense University Hospital, Denmark
Principal Clinical Assessor, Medicines Evaluation Board, The Netherlands
Chief Medical Officer, Altimmune
Chief Scientific Officer, Galmed pharmaceutical Ltd
President and Chief Scientific Officer, WCG – ACI Clinical
CEO, Phenex
Chief Medical Officer, WCG – ACI Clinical
Scientist, Study Director Preclinical, Metabolic Health Research, TNO, The Netherlands
PhD Candidate, University of Minnesota, USA
Medical Director, Accelerated Enrollment Solutions
Valverde, Principal Investigator (Basic Researcher), Spanish National Research Council and CIBERDEM
Director, Pharmacology, Poxel
Professor, University of Ghent, Belgium
Associate Professor,Division of Gastroenterology, Department of Translational and Precision Medicine, University “Sapienza” of Rome Italy
CSO, Cirius Therapeutics
Research Associate, Oxford University
Chief Medical Officer and President, Research & Development, Madrigal Pharmaceuticals, USA
Vice President, Musculoskeletal & Metabolic Imaging, BioTel Research
Reader & Consultant in Hepatology, Barts Liver Centre, Queen Mary University of London, UK
Assistant Professor, Department of Biochemistry and Human Biology, Faculty of Pharmacy, University of Lisbon, Portugal
Reader in Clinical Biochemistry, University of Westminster, UK
Chairman, Division of Gastroenterology and Hepatology, Antwerp University Hospital, Belgium
Professor, University of Cambridge; Associate Director MRC Metabolic Disease Unit; Honorary Consultant Addenbrooke’s Hospital; Scientific Director Cambridge Phenomics Centre; Associate Faculty Sanger Institute
Professor of Hepatology, University of Paris-VII and Visiting Professor of Medicine, UCL
Professor, Virginia Commonwealth University, USA
Director Biomarker Sciences, Gilead Sciences
Professor, Department of Hepatology and Gastroenterology, Charité Berlin, Germany
Consultant Hepatologist, Queen Alexandra Hospital
Professor of Experimental Pathology, Conway Institute, Diabetes Complications Research Centre, University College Dublin, Ireland
Professor of Hepatology and the Head of the Division for the Nottingham Digestive Diseases Centre, University of Nottingham
Chief Medical Officer, Metacrine
Professor of Medicine, Virginia Commonwealth University and Chief of Hepatology & Liver Transplantation, McGuire VA Medical Center, USA
Head of Liver Imaging, Oxford Centre for Clinical Magnetic Resonance Research (OCMR)
Peter Scheuer Chair in Liver Diseases, Deputy Director, UCL Institute for Liver and Digestive Health
Professor, Gastroenterologie am Bayerischen Platz (GBP) Germany
Associate Professor, Unit of Hepatology, Karolinska University Hospital, Sweden
Independent Consultant Gastroenterologist and Hepatologist, Locarno, Ticino, Switzerland
CEO, Genkyotex, Switzerland
Professor, Department Hepatology & Gastroenterology, Aarhus University Hospital
Research Fellow, Nutrition Biomedical Scientist Specialist, University of Southampton, UK
Director International Clinical Development NASH, Allergan
Executive Vice President, Non Clinical Development, Co-Founder, Poxel, France
Professor, Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, USA
President and Chief Executive Officer, Galectin Therapeutics Inc. USA
Vice President, Clinical Development – Liver Disease, Allergan
Associate Professor in clinical nutrition, Head of Clinical Research Unit, Uppsala University, Sweden
Senior Clinical Lecturer in Endocrinology, Department of Metabolism, Digestion and Reproduction, Imperial College, UK
Consultant Hepatologist, Queen Alexandra Hospital, UK
Principal Technical Adviser, NICE Scientific Advice
CEO Liver Consulting ; Former Head of Liver Disease Development, Takeda
Chief Medical officer, SomaLogic
Research Director of Cardiometabolic Risk Unit, Institute of Clinical Physiology, CNR, Pisa Italy & Professor of Medicine, UT Health Science Center San Antonio, TX, USA
Chief Medical Officer, Danish Medicines Agency, Consultant Gastroenterologist, Odense University Hospital, Denmark
Principal Clinical Assessor, Medicines Evaluation Board, The Netherlands
Chief Medical Officer, Altimmune
Chief Scientific Officer, Galmed pharmaceutical Ltd
President and Chief Scientific Officer, WCG – ACI Clinical
CEO, Phenex
Chief Medical Officer, WCG – ACI Clinical
Scientist, Study Director Preclinical, Metabolic Health Research, TNO, The Netherlands
PhD Candidate, University of Minnesota, USA
Medical Director, Accelerated Enrollment Solutions
Valverde, Principal Investigator (Basic Researcher), Spanish National Research Council and CIBERDEM
Director, Pharmacology, Poxel
Professor, University of Ghent, Belgium
Associate Professor,Division of Gastroenterology, Department of Translational and Precision Medicine, University “Sapienza” of Rome Italy
CSO, Cirius Therapeutics
Research Associate, Oxford University
Chief Medical Officer and President, Research & Development, Madrigal Pharmaceuticals, USA
Vice President, Musculoskeletal & Metabolic Imaging, BioTel Research
Reader & Consultant in Hepatology, Barts Liver Centre, Queen Mary University of London, UK
Assistant Professor, Department of Biochemistry and Human Biology, Faculty of Pharmacy, University of Lisbon, Portugal
Reader in Clinical Biochemistry, University of Westminster, UK
Chairman, Division of Gastroenterology and Hepatology, Antwerp University Hospital, Belgium
Professor, University of Cambridge; Associate Director MRC Metabolic Disease Unit; Honorary Consultant Addenbrooke’s Hospital; Scientific Director Cambridge Phenomics Centre; Associate Faculty Sanger Institute
Professor of Hepatology, University of Paris-VII and Visiting Professor of Medicine, UCL
Professor, Virginia Commonwealth University, USA
Director Biomarker Sciences, Gilead Sciences
Professor, Department of Hepatology and Gastroenterology, Charité Berlin, Germany
Consultant Hepatologist, Queen Alexandra Hospital
Professor of Experimental Pathology, Conway Institute, Diabetes Complications Research Centre, University College Dublin, Ireland
Professor of Hepatology and the Head of the Division for the Nottingham Digestive Diseases Centre, University of Nottingham
Chief Medical Officer, Metacrine
Professor of Medicine, Virginia Commonwealth University and Chief of Hepatology & Liver Transplantation, McGuire VA Medical Center, USA
Head of Liver Imaging, Oxford Centre for Clinical Magnetic Resonance Research (OCMR)
Peter Scheuer Chair in Liver Diseases, Deputy Director, UCL Institute for Liver and Digestive Health
Professor, Gastroenterologie am Bayerischen Platz (GBP) Germany
Associate Professor, Unit of Hepatology, Karolinska University Hospital, Sweden
Independent Consultant Gastroenterologist and Hepatologist, Locarno, Ticino, Switzerland
CEO, Genkyotex, Switzerland
Professor, Department Hepatology & Gastroenterology, Aarhus University Hospital
Research Fellow, Nutrition Biomedical Scientist Specialist, University of Southampton, UK
Track hop and access all presentations
Give a poster presentation
Join networking discussion rooms
Access the virtual exhibition room
Priority networking with other attendees
Create post-event connections
Conference workbook
Presentations will be available on-demand shortly after the meeting
Register for three, five or ten passes for a substantial discount
Not applicable for solution provider companies or compatible with any other offers or discount codes.
Option 1 – Please phone +44 (0) 1865 671957 ext. 207 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
Organisations offering services and/or business & technology solutions and business consultants please contact Tony Couch or Gavin Hambrook to discuss participation at this meeting.
The fees shown are available to industry, academics and not for profit organisations.
To help us comply with GDPR (privacy regulations) please register using your official institution email address and not a personal email.
Excellent value
Click here to get three passes for just €750
299.00€
The standard fee gives you full access to all the live presentations and post-event on-demand viewing as well as interactive networking tools.
799.00€
This fee applies to organisations offering services and/or business & technology solutions and also to business consultants.
Owlstone Medical’s goal is to realize the enormous healthcare and economic promise of breath-based diagnostics through the development and application of Breath Biopsy®, which operates by detecting volatile organic compounds (VOCs) produced as the end product of metabolic processes within the body or as a result of chemicals from external sources.
Owlstone Medical is in the unique position of establishing a new diagnostic modality in breath that has substantial advantages over blood as a core sample type for clinicians and for academic and pharmaceutical researchers for the early detection of disease and to enable precision medicine approaches to patient care.
http://www.owlstonemedical.com/
×
Aiforia is a versatile cloud-based platform that increases the speed and accuracy of analyzing medical images across a variety of fields by providing healthcare professionals direct access to deep learning AI. Aiforia assists with the increased demand for image-based diagnostics by providing efficient and scalable solutions – enabling new discoveries, clinical support and highly accurate and consistent data.
×SomaLogic seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals to optimize their health and wellness throughout their lives. We work with a global network of partners and users to derive and deliver this information through the SomaScan® Platform, SomaLogic’s proprietary protein measurement technology, across many different health-related markets and providers. To learn more about us and how you can work with us to transform your own healthcare efforts, visit http://somalogic.com/somascan-access.
×At Thermo Fisher Scientific, our mission is to enable our customers to make the world healthier, cleaner and safer. Gibco media, supplements, cells, and cell culture reagents are designed to deliver reproducibility and performance for results you can count on every day. Regardless of whether you are performing cell culture in research labs, need a special or defined formulation, or are growing cell lines, primary, or stem cells, Gibco products offer a reliable solution.
https://www.thermofisher.com/us/en/home/brands/gibco.html
×As the Research Division of BioTelemetry, Inc., BioTel Research offers medical imaging and cardiac safety testing services for clinical trials – supporting the advancement of biopharmaceutical development worldwide. With an ideal combination of global experience and personal access, BioTel Research combines the agility and accessibility of a small lab with the reach and experience of a large clinical trials services provider.
www.gobio.com/clinical-research/
×Cerba Research provides the highest quality specialized laboratory and diagnostic solutions while leveraging patient data and scientific insight to shape and advance clinical trials. With our global footprint and access to leading regional labs, data, patients, technology, and partnered resources, we support global biotech, pharma, and IVD organizations to improve the lives of patients around the world.
https://www.cerbaresearch.com/
×Accelerated Enrollment Solutions (AES) is the new standard in clinical trial productivity. Our innovative and integrated site and patient services secure the success of clinical trials by providing enrolment, timing, and budget certainty. AES offers sponsors and contract research organizations best-in-class site conduct and patient access solutions, which include engaging, recruiting and retaining patients in clinical studies via a global network of dedicated research sites.
×Established in 2007, Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. Our digital health solution, Simoa®, has the potential to change today’s approach to healthcare by giving researchers the ability to closely examine the continuum from health to disease. Simoa® is designed to enable earlier disease detection, better prognoses and enhanced treatment methods. Current research applications include oncology, neurology, immunology, infectious disease and cardiology.
×
TNO Healthy Living is the innovation partner that in joint cooperation with the public and private sector enables technological and social innovations that support citizens and professionals to make the right (preventive) choices that promote a healthy, vital and productive population. In this way we act as the flywheel of innovation that supports improved affordability and quality of health, lower healthcare costs and sustainable economic growth.
×In 2003, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the unique device using patented and validated VCTE™ technology for liver stiffness assessment, and CAP™ technology for steatosis quantification.
FibroScan® device is recognized worldwide as the reference for non invasive liver diagnosis with more than 2,000 medical publications and 40 guidelines recommendations.
We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH.
As patient education is a major issue, we have created the “myliverexam” website that provides information about the role of the liver and why it is vital to the global health.
×As innovators in the rapidly-evolving medical education landscape, Liberum IME, (part of OPEN Health) continually finds creative solutions to deliver globally-relevant science in the context of local practice. Our evidence-based education is tailored to the specific needs of healthcare professionals, inspiring self-reflection to drive measurable practice change and improve patient care. We are dedicated to sharing best practice through international collaboration, allowing healthcare professionals worldwide to put science into practice.
×PRA Health Sciences delivers innovative drug development solutions that improve patients’ lives. Our people work tirelessly to provide quality results for clients. We offer specialized expertise across all phases and therapeutic areas and a broad spectrum of full-service and strategic solutions.
With 16,000+ employees covering 90+ countries, we give you the global presence you expect, combined with an in-depth knowledge of local regulations, standards of care, and cultural customs.
At PRA, we love what do, because we are making a difference in the lives of patients and their family members worldwide. We have contributed to the development of numerous drugs now available.
×Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and/or increase brand awareness by taking a poster position or sponsoring the poster sessions. This can be supplemented by branding options such as placing your logo on the meeting background screen.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas. The booth allows you to provide a pre-recorded video or deliver a live video session to your visitors and capture emails when people register their interest. Live chat with your visitors in discussion groups or 1:1.
Options include:
For further details please contact
Tony Couch or Gavin Hambrook
Telephone +44 (0) 1865 849841
Search the Antibody Resource database of 2 million antibody and Elisa products from 170 suppliers covering 27000 proteins.
With thousands of proteins and often hundreds of associated antibodies, the selection of a specific antibody can be both time-consuming and expensive. Antibody Resource is spearheading a unique initiative designed to compare antibodies from numerous suppliers using identical samples/tissues and an identical protocol. In doing so, we hope to enable scientists to form an unrivalled opinion of which is the most suitable antibody for their research and in particular.
×An STM journal publisher of online and print and open access journals, and related print/online book series, Bentham Science answers the informational needs of the pharmaceutical, biomedical and medical research community.
×Biomall.in is an online e-commerce marketplace that ships lab reagents, lab equipment & supplies worldwide. Visit Biomall.in now to buy laboratory, life science & diagnostic products from India.
×Biomedicines is an open access journal devoted to research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. The aim of Biomedicines is publishing high quality papers that address the challenges in bringing biological agents or novel targeted strategies through identification, development and ultimately to clinical use. Therefore, basic research, comprehensive preclinical studies, clinical development, and clinical trials are all within the scope of the journal.
https://www.mdpi.com/journal/biomedicines/special_issues/NASH
×BioVox is a specialized life sciences news and communication platform keeping you up to date on the rapidly evolving life sciences sector in Belgium and on global scientific and industry trends. BioVox brings exclusive news, in-depth interviews, opinions, and insights on healthcare, agriculture and the bio-based economy.
×Global Information, Inc. is an information service company holding offices in 6 countries and have sales agency contracts with over 300 research companies around the world. We sell 30,000 market research reports published by these publishers and accept custom-made researches.
×Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace.
×The Fatty Liver Foundation was created by patients for patients. Our goal is to save the lives of people who have no symptoms but are unknowingly destroying their livers. We aim to provide them with information that can help them change their lifestyle before they become ill. It is the mission, duty and purpose of the Fatty Liver Foundation to address, educate, coordinate, and support victims of the growing epidemic of fatty liver disease.
×Hep is an award-winning print and online brand for people living with and affected by viral hepatitis. Offering unparalleled editorial excellence since 2010, Hep and HepMag.com are the go-to source for educational and social support for people living with hepatitis.
×Hospital Management is the largest web-based online platform that provides the latest information started operating for 7 years. Hospital Management has reinvented itself to be the best amongst the industry updating various technical aspects in the Hospital Sector.
×Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry, keeping a tab on the updated and latest updates and trends concerning the field.
×Pharmaceutical Tech is the most prominent online platform focuses on current happenings and has been operating for more than a decade. Pharmaceutical Tech is a leading advertising platform for the suppliers who wish to showcase their product lineups to the buyers. Pharmaceutical Tech provides an in-depth analysis of news and articles focusing on the latest trends widespread across the globe.
×Pharma Tech Outlook is a monthly publication that has been bringing forth real-world solutions, news, product trends, solutions and much more to subscribers. The unique learn-from-peers approach is creating a difference since the decision-makers are constantly sharing their experience, wisdom and thought leadership with each other.
×PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
×RxNet is a free online community, uniting scientists from the fields of chemistry, biochemistry and beyond to further the ever-booming industry of drug discovery and development.
×World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives.
×